150 related articles for article (PubMed ID: 25629913)
1. Pharmacokinetics of pergolide after intravenous administration to horses.
Rendle DI; Hughes KJ; Doran GS; Edwards SH
Am J Vet Res; 2015 Feb; 76(2):155-60. PubMed ID: 25629913
[TBL] [Abstract][Full Text] [Related]
2. Single-dose oral pharmacokinetics of pergolide mesylate in healthy adult mares.
Gehring R; Beard L; Wright A; Coetzee J; Havel J; Apley M
Vet Ther; 2010; 11(1):E1-8. PubMed ID: 20949429
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of pergolide mesylate after oral administration in horses with pituitary pars intermedia dysfunction.
Rendle DI; Doran G; Ireland J; Edwards S
Domest Anim Endocrinol; 2019 Jul; 68():135-141. PubMed ID: 31082785
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction.
McFarlane D; Banse H; Knych HK; Maxwell LK
J Vet Pharmacol Ther; 2017 Apr; 40(2):158-164. PubMed ID: 27301465
[TBL] [Abstract][Full Text] [Related]
5. Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
Jacobson GA; Pirie A; Edwards S; Hughes KJ; Rendle DI; Davies NW
J Pharm Biomed Anal; 2014 Jun; 94():54-7. PubMed ID: 24549007
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of pergolide in Parkinson's disease.
Blin O
Curr Opin Neurol; 2003 Dec; 16 Suppl 1():S9-12. PubMed ID: 15180132
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic properties of pergolide mesylate following single and multiple-dose administration in donkeys (Equus asinus).
Xue C; Davis J; Berghaus LJ; Hanafi A; Vaughn SA; Hart KA
Equine Vet J; 2023 Nov; 55(6):1078-1085. PubMed ID: 36572900
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of firocoxib after administration of multiple consecutive daily doses to horses.
Letendre LT; Tessman RK; McClure SR; Kvaternick VJ; Fischer JB; Hanson PD
Am J Vet Res; 2008 Nov; 69(11):1399-405. PubMed ID: 18980421
[TBL] [Abstract][Full Text] [Related]
9. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
Fortin JS; Benskey MJ; Lookingland KJ; Patterson JS; Howey EB; Goudreau JL; Schott HC
BMC Vet Res; 2020 Sep; 16(1):356. PubMed ID: 32977825
[TBL] [Abstract][Full Text] [Related]
10. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease).
Donaldson MT; LaMonte BH; Morresey P; Smith G; Beech J
J Vet Intern Med; 2002; 16(6):742-6. PubMed ID: 12465775
[TBL] [Abstract][Full Text] [Related]
11. Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.
Thalamas C; Rajman I; Kulisevsky J; Lledó A; Mackie AE; Blin O; Gillespie TA; Seger M; Rascol O
Clin Neuropharmacol; 2005; 28(3):120-5. PubMed ID: 15965310
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of single-dose intragastric and intravenous pregabalin administration in clinically normal horses.
Mullen KR; Schwark W; Divers TJ
Am J Vet Res; 2013 Jul; 74(7):1043-8. PubMed ID: 23802677
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
Wearn JM; Crisman MV; Davis JL; Geor RJ; Hodgson DR; Suagee JK; Ashraf-Khorassani M; McCutcheon LJ
J Vet Pharmacol Ther; 2011 Jun; 34(3):252-8. PubMed ID: 21492190
[TBL] [Abstract][Full Text] [Related]
14. The analysis of pergolide residues in horse plasma by LC with fluorescence detection.
Doran G; Hughes K; Rendle D; Edwards S
J AOAC Int; 2013; 96(6):1487-93. PubMed ID: 24645533
[TBL] [Abstract][Full Text] [Related]
15. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP
Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse.
Grimsrud KN; Mama KR; Steffey EP; Stanley SD
Vet Anaesth Analg; 2012 Jan; 39(1):38-48. PubMed ID: 22103480
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and selected pharmacodynamics of trazodone following intravenous and oral administration to horses undergoing fitness training.
Knych HK; Mama KR; Steffey EP; Stanley SD; Kass PH
Am J Vet Res; 2017 Oct; 78(10):1182-1192. PubMed ID: 28945130
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
Dimaio Knych HK; Stanley SD
Am J Vet Res; 2011 Oct; 72(10):1378-85. PubMed ID: 21962281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
